Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA

BACKGROUND: The Mechanism of Coordinated Access to Orphan Medicinal Products (MoCA) was established in 2013 with the intention of developing a coordinated mechanism between volunteering EU stakeholders and developers of Orphan Medicinal Products (OMPs) to support the exchange of information aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavaller-Bellaubi, Maria, Hughes-Wilson, Wills, Kubinová, Šárka, Van de Casteele, Marc, Van Lente, Evert Jan, Degortes, Emanuele, Pontén, Johan, Eichler, Hans-Georg, Le Cam, Yann, Boselli, Simone, Bucsics, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258756/
https://www.ncbi.nlm.nih.gov/pubmed/37308991
http://dx.doi.org/10.1186/s13023-023-02774-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258756/
https://www.ncbi.nlm.nih.gov/pubmed/37308991
http://dx.doi.org/10.1186/s13023-023-02774-7

Ejemplares similares